Cargando…

Hepatitis C Transmission after Prostate Biopsy

Prostate biopsy is a current and well-codified procedure; antibiotic prophylaxis and rectal enema limit the risk of infection. To date, there has been no reported viral transmission between patients due to a contaminated ultrasound probe. In this study, we report the case of a patient who contracted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferhi, Karim, Rouprêt, Morgan, Mozer, Pierre, Ploussard, Guillaume, Haertig, Alain, de La Taille, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600139/ https://www.ncbi.nlm.nih.gov/pubmed/23533934 http://dx.doi.org/10.1155/2013/797248

Ejemplares similares

Chromogranin A: a useful biomarker in castration-resistant prostate cancer
por: Ploussard, Guillaume, et al.
Publicado: (2022)

How to deal with steroids use in the management of metastatic prostate cancer during pandemic
por: Baboudjian, Michael, et al.
Publicado: (2020)

Online Public Interest in Urological Cancers During the COVID-19 Pandemic: What Can “Dr. Google” Teach Us?
por: Khene, Zine-Eddine, et al.
Publicado: (2022)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
por: Touzani, Alae, et al.
Publicado: (2022)

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016)

The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is “Safe Better than Sorry”?
por: Pradère, Benjamin, et al.
Publicado: (2020)

Overview of the Development and Use of Akt Inhibitors in Prostate Cancer
por: Gasmi, Anis, et al.
Publicado: (2021)

Biomarker in Active Surveillance for Prostate Cancer: A Systematic Review
por: Manceau, Cécile, et al.
Publicado: (2021)

Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
por: Gauthé, Mathieu, et al.
Publicado: (2021)

Independent Evaluation of the Respective Predictive Values for High-Grade Prostate Cancer of Clinical Information and RNA Biomarkers after Upfront MRI and Image-Guided Biopsies
por: Roumiguié, Mathieu, et al.
Publicado: (2020)

Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU)
por: Saouli, Amine, et al.
Publicado: (2023)

Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis
por: Baboudjian, Michael, et al.
Publicado: (2022)

PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers
por: Teyssonneau, Diego, et al.
Publicado: (2022)

Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy
por: Manceau, Cécile, et al.
Publicado: (2020)

Trends in the placement of penile prostheses over the last 17 years in France
por: Léon, Priscilla, et al.
Publicado: (2015)

Oncologic Impact and Safety of Pre-Operative Radiotherapy in Localized Prostate and Bladder Cancer: A Comprehensive Review from the Cancerology Committee of the Association Française d’Urologie
por: Sargos, Paul, et al.
Publicado: (2021)

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction
por: Ploussard, Guillaume, et al.
Publicado: (2020)

Risk Estimation of Metastatic Recurrence After Prostatectomy: A Model Using Preoperative Magnetic Resonance Imaging and Targeted Biopsy
por: Bommelaere, Thomas, et al.
Publicado: (2022)

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
por: Terry, Stéphane, et al.
Publicado: (2015)

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
por: Terry, Stéphane, et al.
Publicado: (2019)

External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)
por: Khene, Zine-Eddine, et al.
Publicado: (2021)

Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2020)

Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic
por: Pinar, Ugo, et al.
Publicado: (2020)

Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes
por: Tsaur, Igor, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on oncological and functional robotic-assisted surgical procedures
por: Blanc, Thomas, et al.
Publicado: (2021)

Long-term outcomes after penile prosthesis placement for the Management of Erectile Dysfunction: a single-Centre experience
por: Frydman, Valentine, et al.
Publicado: (2021)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study)
por: Margue, Gaelle, et al.
Publicado: (2023)

Online public interest in urological cancers during the Covid-19 pandemic: What can “Dr. Google” teach us?
por: Khene, Z-E., et al.
Publicado: (2022)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Balaban, Muhsin, et al.
Publicado: (2020)

Risk Factors for Acute Prostatitis after Transrectal Biopsy of the Prostate
por: Kim, Sang Jin, et al.
Publicado: (2010)

Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy
por: Bang, Jun-Ho, et al.
Publicado: (2013)

New Bacterial Infection in the Prostate after Transrectal Prostate Biopsy
por: Seo, Yumi, et al.
Publicado: (2018)

Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer
por: Diamant, Elliott, et al.
Publicado: (2022)

Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797
por: Diamant, Elliott, et al.
Publicado: (2022)

Effects of hexanic extract of serenoa repens (permixon(®) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
por: Latil, Alain, et al.
Publicado: (2015)

Increased expression of class III β-tubulin in castration-resistant human prostate cancer
por: Terry, S, et al.
Publicado: (2009)

Actualisation du risque lié à la corticothérapie en association à l’acétate d’abiratérone en période de pandémie COVID-19
por: Rozet, F., et al.
Publicado: (2021)

Risk stratification for upper tract urinary carcinoma
por: Benamran, Daniel, et al.
Publicado: (2020)

Editorial Comment: Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
por: Diniz, Andre Luiz Lima
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ohkh5qviq8fnseq67tmcof618